Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  cardiovascular complications
Trial Type:  Supportive care
Results 1-16 of 16 for your search:
Start Over
Atorvastatin Calcium in Preventing Cardiovascular Complications in Patients with Newly Diagnosed Stage I-III Breast Cancer or Lymphoma Undergoing Anthracycline-Based Chemotherapy
Phase: Phase III, Phase II
Type: Supportive care
Age: 30 to 80
Trial IDs: 98213, NCI-2013-01760, 00024197, CCCWFU 98213, WF 98213, WFU 98213, NCT01988571
Bortezomib or Carfilzomib with Lenalidomide and Dexamethasone in Treating Patients with Newly Diagnosed Multiple Myeloma
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: E1A11, NCI-2012-02608, ECOG-E1A11, NCT01863550
Pharmacologic Reversal of Ventricular Remodeling in Childhood Cancer Survivors at Risk for Congestive Heart Failure (PREVENT-CHF): A Phase IIB Randomized Placebo-Controlled Trial
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 16 and over
Trial IDs: 11018, NCI-2011-00717, 104062, NCT01347970
Atorvastatin Calcium in Improving Cardiovascular Function in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Phase: Phase II
Type: Supportive care
Age: 18 to 39
Trial IDs: 1207M17202, NCI-2012-01743, 2012NTLS051, NCT01733953
Simvastatin in Reducing Cardiac Toxicity in Patients with Stage I-III Breast Cancer Receiving Chemotherapy
Phase: Phase II
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: J13160, NCI-2014-01435, CIR00005458, JHMIRB 6, NA_00091900 / CIR00008150, SKCCC J13160, NCT02096588
Carvedilol in Preventing Therapy-Associated Cardiotoxicity in Patients with HER2-Positive Breast Cancer
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: 14-099, NCI-2014-01464, NCT02177175
A Study in Cancer Patients to Evaluate the Effect of a Single Dose of NKTR-102 (Etirinotecan Pegol) on the QTc Interval and to Assess Pharmacokinetics and Safety
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: 12-102-12, NCI-2014-00806, NCT01976143
Effect of MLN0128 on the QTc Interval in Participants With Advanced Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Supportive care
Age: 18 and over
Trial IDs: C31002, NCI-2014-01846, U1111-1156-4099, NCT02197572
Evaluation of the Effect of Lurbinectedin (PM01183) on Cardiac Repolarization in Patients With Selected Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Age: 65 and under
Trial IDs: PM1183-B-005-14-QT, NCI-2015-01174, NCT02451007
Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: CCCWFU 98509, NCI-2010-00125, NCT01051401
Exercise Therapy and Quality of Life in Postmenopausal Early Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy
Phase: No phase specified
Type: Educational/Counseling/Training, Supportive care
Age: Not specified
Trial IDs: 1B-12-1, NCI-2010-01265, HS-12-00141, NCT01140282
Proton Beam Radiation Therapy in Treating Patients with Breast Cancer Who Have Undergone Surgery
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 10-205, NCI-2011-02713, NCT01340495
MRI in Detecting Heart Damage in Patients with Cancer Receiving Chemotherapy
Phase: No phase specified
Type: Diagnostic, Supportive care
Age: 22 and over
Trial IDs: CCCWFU 99112, NCI-2012-01613, NCT01719562
Cardiac Magnetic Resonance Imaging in Detecting Cardiac Toxicity Caused by Doxorubicin Hydrochloride-Based Chemotherapy in Patients With Lymphoma
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic, Supportive care
Age: 18 and over
Trial IDs: 11-443, NCI-2012-00537, NCT02055040
Cardiorespiratory Function in Patients with Metastatic Hormone-Resistant Prostate Cancer Undergoing Treatment with Sipuleucel-T, Abiraterone Acetate, or Enzalutamide
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: Pro00058229, NCI-2015-00581, NCT02353715
Start Over